-performing assets (NPAs) totaling Baht 321 million and had gain of Baht 162 million. Financial Markets business generated revenue of Baht 126 million during 3Q19. For Capital market business, the market shares

% Cash 1,053,824 1,335,668 (281,844) (21.1) Interbank and money market items, net 7,201,505 28,199,589 (20,998,084) (74.5) Derivatives assets 4,073,862 3,315,858 758,004 22.9 Investments in securities, net

investment consultants: revoking approval of Auracha Vachirakulthon as securities investment consultant for 10 years, starting from December 22, 2015, and suspending approval of {B} and {C} as capital market

consequently affect confidence in securities business and the capital market at large;      (2) Custody of clients? assets: deficiency of the verification process created risk of damaging client assets. It was

of December 31, 2018 are summarized as below:  Assets As of March 31, 2018, the Company and its subsidiaries had a total asset by 680.8 MB which decreased from December 31, 2018 by 21.8 MB as a result

- Translation- June 11, 2019 Subject: Notification the Acquisition of share of BS Myco Biotech Company Limited. (Additional Information Memorandum Concerning the Acquisition of Assets) To: Director and Manager

Companies For Personnels (FM/IC/IP/Analyst) Digital Assets For Business Operators SEC News see more > 09/08/2024 | No 165 / 2024 SEC launches Digital Asset Regulatory Sandbox on https://www.sec.or.th/EN/Pages

Ref.No.IVL004/03/2018 21st March 2018 President The Stock Exchange of Thailand Subject: Indorama Ventures enters into a Joint Venture to acquire the integrated PTA- PET assets in Corpus Christi, Texas, USA

transaction is not considered as material transaction, as the highest value of transaction size is calculated to be 4% of net tangible assets of the Company. Comparison of Consideration Paid criteria and the

disposal of the assets does not cause the Company to fall within the disclosure requirement under the Notification of the Capital Market Supervisory Board No. TorJor 20/2551 Director who have conflict of